Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BASKING RIDGE, N.J., March 29, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences (NASDAQ:CLBS), (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and...
-
BASKING RIDGE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a cell therapy company combining an industry-leading development and manufacturing...
-
Quarterly Growth of 43% and Annual Growth of 25% versus Prior Year Driven by PCT Clinical Services Revenues Conference Call Begins Today at 5:00 pm Eastern Time BASKING RIDGE, N.J., March 15,...
-
Caladrius Sells 19.9% Equity Stake in PCT for $19.4 Million Licenses Cell Therapy Technology for Certain Asian Territories for $5.6 Million and Future Royalties BASKING RIDGE, N.J., March 14,...
-
BASKING RIDGE, N.J., March 08, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a cell therapy company combining an industry-leading development and manufacturing...
-
BASKING RIDGE, N.J., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
BASKING RIDGE, N.J., Jan. 28, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
BASKING RIDGE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
BASKING RIDGE, N.J., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
Emphasizes PCT subsidiary’s leadership position in the emerging cell therapy market with expectations for >30% revenue growth in 2016 Focuses clinical development on innovative platform of immune...